Vital Signs: Actionable charts
In this product we rank the most positive and negative domestic stocks, filter the symbols by market-cap and trading volume, and then divide the companies into sectors and groups. We then manually look through charts leadership/changes, bottoms-up/top-down ideas, short-term patterns that may have long-term significance, etc. We believe you will find this product valuable as significant price and relative moves begin in the daily charts.Allied Motion Technologies designs, manufactures and sells precision and specialty controlled motion components and systems used in a range of industries. The company's target markets include Vehicle, Medical, Aerospace and Defense, and Industrial. The company is focused on electro-magnetic, mechanical and electronic motion technology. The company's products include brush and brushless DC motors, brushless servo and torque motors, coreless DC motors, integrated brushless motor-drives, gearmotors, gearing, modular digital servo drives, motion controllers, incremental and absolute optical encoders, active and passive filters for power quality and harmonic issues, and other controlled motion-related products.
Capricor Therapeutics is a clinical-stage biotechnology company focused on the discovery, development and commercialization of biological therapies for the treatment of diseases, with a focus on Duchenne muscular dystrophy (DMD), and other rare disorders. The company's drug candidates in active development consist of: CAP-1002 (allogeneic cardiosphere-derived cells (CDCs)), which is for the treatment of DMD, advanced heart failure and myocardial infarction; and CAP-2003 (CDC extracellular vesicles, including exosomes), which is for the treatment of inflammatory conditions. CAP-2003 is in pre-clinical development.
National Research is a provider of analytics and insights that facilitate measurement and improvement of the patient and employee experience while also increasing patient engagement and customer loyalty for healthcare organizations. The company's portfolio of subscription-based solutions provides information and analysis to healthcare organizations across a range of elements, including patient experience, service recovery, care transitions, health risk assessments, employee engagement, reputation management and brand loyalty. The company partners with clients across the continuum of healthcare services. The company's clients include integrated health systems, post-acute providers and payer organizations.
Penumbra is a healthcare company. The company designs, develops, manufactures and markets medical devices. The company's Neuro products include Penumbra System brand of products that provides a form of mechanical thrombectomy used by specialist physicians to revascularize blood vessels that are blocked by clots in the intracranial vasculature. The company's Vascular products include the Ruby Coil System that consists of detachable coils and is used in clinical applications auch as active extravasations, or the escape of blood into surrounding tissue, selective embolization in patients with visceral aneurysms, embolization in patients with gastrointestinal bleeding, and high flow arterial venous malformations.
Provident Financial Holdings is a savings and loan holding company. The company's subsidiary, Provident Savings Bank, F.S.B. (the Bank), is a federally chartered stock savings bank. The Bank is a financial services company focused on serving consumers and small to mid-sized businesses in the Inland Empire region of Southern California. The lending activity of the Bank is primarily comprised of the origination of single-family, multi-family and commercial real estate loans and, construction, commercial business, consumer and other mortgage loans to be held for investment. The Bank also provides a selection of deposit instruments, including checking, savings, money market and time deposits.
Regeneron Pharmaceuticals is a biotechnology company that discovers, invents, develops, manufactures, and commercializes medicines for the treatment of diseases. The company's commercialized medicines and product candidates in development are designed to assist patients with eye disease, allergic and inflammatory diseases, cancer, cardiovascular and metabolic diseases, neuromuscular diseases, infectious diseases, and rare diseases. The company's products include: EYLEA (aflibercept) injection, which is used for the treatment of neovascular age-related macular degeneration, diabetic macular edema; and Dupixent (dupilumab) injection, which is used for the treatment of adult patients with atopic dermatitis.
Vermilion Research delivers timely, actionable, and unique research inputs to professional investors. Our research strategists highlight securities which we believe are at major inflection points, based on our various proprietary technical indicators, and offer asymmetric risk/return profiles. We believe our research methodology, which is not limited by industry sector or market capitalization, enables us to deliver superior investment recommendations.
Our process begins by organizing all actively traded stocks into coherent sectors, then into logical industry groups. We then apply our proprietary relative strength tools to identify developing price trends. Once attractive trends are identified within a selected sectors or groups, we screen for individual stocks which we believe offer the best risk/reward profile. Vermilion offers U.S. and global equity market research products. Vermilion’s research team, which has received numerous awards and accolades, has a combined 70 year of experience in the analysis of investment securities.
Unfortunately, this report is not available for the investor type or country you selected.
Browse all ResearchPool reportsReport is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.